RHON-KLINIKUM AG (GB:0NQH)
LSE:0NQH
Total Valuation
RHON-KLINIKUM AG has a market cap or net worth of €836.73M. The enterprise value is €788.65M.
Market Cap€836.73M
Enterprise Value€788.65M
Share Statistics
RHON-KLINIKUM AG has 66,962,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66,962,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RHON-KLINIKUM AG’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 0.24%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)0.24%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee102.86K
Profits Per Employee1.83K
Employee Count18,819
Asset Turnover1.06
Inventory Turnover43.57
Valuation Ratios
The current PE Ratio of RHON-KLINIKUM AG is 20.4. RHON-KLINIKUM AG’s PEG ratio is -1.23.
PE Ratio20.4
PS Ratio0.44
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-24.57
Price to Operating Cash Flow0.00
PEG Ratio-1.23
Income Statement
In the last 12 months, RHON-KLINIKUM AG had revenue of 1.94B and earned 34.47M in profits. Earnings per share was 0.52.
Revenue1.94B
Gross Profit167.75M
Operating Income4.39M
Pretax Income44.95M
Net Income34.47M
EBITDA69.40M
Earnings Per Share (EPS)0.52
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
RHON-KLINIKUM AG pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.21
52-Week Price Change-15.43%
50-Day Moving Average12.92
200-Day Moving Average12.37
Relative Strength Index (RSI)38.59
Average Volume (3m)2.00
Important Dates
RHON-KLINIKUM AG upcoming earnings date is May 7, 2026, Before Open (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
RHON-KLINIKUM AG as a current ratio of 2.60, with Debt / Equity ratio of 9.25%
Current Ratio2.60
Quick Ratio2.49
Debt to Market Cap0.14
Net Debt to EBITDA-0.69
Interest Coverage Ratio1.46
Taxes
In the past 12 months, RHON-KLINIKUM AG has paid 8.67M in taxes.
Income Tax8.67M
Effective Tax Rate0.19
Enterprise Valuation
RHON-KLINIKUM AG EV to EBITDA ratio is 11.56, with an EV/FCF ratio of -23.18.
EV to Sales0.41
EV to EBITDA11.56
EV to Free Cash Flow-23.18
EV to Operating Cash Flow12.43
Balance Sheet
RHON-KLINIKUM AG has €346.19M in cash and marketable securities with €146.87M in debt, giving a net cash position of €199.32M billion.
Cash & Marketable Securities€346.19M
Total Debt€146.87M
Net Cash€199.32M
Net Cash Per Share€2.98
Tangible Book Value Per Share€17.68
Margins
Gross margin is 15.73%, with operating margin of 0.23%, and net profit margin of 1.78%.
Gross Margin15.73%
Operating Margin0.23%
Pretax Margin2.32%
Net Profit Margin1.78%
EBITDA Margin3.59%
EBIT Margin0.23%
Analyst Forecast
The average price target for RHON-KLINIKUM AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―